Patents by Inventor Wolfgang Sohngen

Wolfgang Sohngen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NON-NEUROTOXIC PLASMINOGEN ACTIVATING FACTORS FOR TREATING OF STROKE
    Publication number: 20170051268
    Abstract: The invention concerns the use and the production of non-neurotoxic plasminogen activating factors, derived, for example, from the common vampire Desmodus rotundus (DSPA), for therapeutic treatment of stroke in humans. The invention provides a novel therapeutic base for treating stroke in humans.
    Type: Application
    Filed: March 24, 2016
    Publication date: February 23, 2017
    Inventors: Mariola SOHNGEN, Wolfgang SOHNGEN, Wolf-Dieter SCHLEUNING, Robert MEDCALF
  • NON-NEUROTOXIC PLASMINOGEN ACTIVATING FACTORS FOR TREATING OF STROKE
    Publication number: 20140199287
    Abstract: The invention concerns the use and the production of non-neurotoxic plasminogen activating factors, derived, for example, from the common vampire Desmodus rotundus (DSPA), for therapeutic treatment of stroke in humans. The invention provides a novel therapeutic base for treating stroke in humans.
    Type: Application
    Filed: January 9, 2014
    Publication date: July 17, 2014
    Applicant: H. LUNDBECK A/S
    Inventors: Mariola SOHNGEN, Wolfgang SOHNGEN, Wolf-Dieter SCHLEUNING, Robert MEDCALF
  • NON-NEUROTOXIC PLASMINOGEN ACTIVATING FACTORS FOR TREATING OF STROKE
    Publication number: 20130039902
    Abstract: The invention concerns the use and the production of non-neurotoxic plasminogen activating factors, derived, for example, from the common vampire Desmodus rotundus (DSPA), for therapeutic treatment of stroke in humans. The invention provides a novel therapeutic base for treating stroke in humans.
    Type: Application
    Filed: February 10, 2012
    Publication date: February 14, 2013
    Applicant: H. Lundbeck A/S
    Inventors: Mariola Sohngen, Wolfgang Sohngen, Wolf-Dieter Schleuning, Robert Medcalf
  • Non-neurotoxic plasminogen activating factors for treating of stroke
    Patent number: 8119597
    Abstract: The invention concerns the use and the production of non-neurotoxic plasminogen activating factors, derived, for example, from the common vampire Desmodus rotundus (DSPA), for therapeutic treatment of stroke in humans. The invention provides a novel therapeutic base for treating stroke in humans.
    Type: Grant
    Filed: August 22, 2008
    Date of Patent: February 21, 2012
    Assignee: Paion GmbH
    Inventors: Mariola Sohngen, Wolfgang Sohngen, Wolf-Dieter Schleuning, Robert Medcalf
  • Non-neurotoxic plasminogen activating factors for treating stroke
    Patent number: 8071091
    Abstract: The invention pertains to the use and production of non-neurotoxic plasminogen activating factors e.g. of Desmodus rotundus (DSPA) for the therapeutic treatment of stroke in humans in order to provide a new therapeutic concept for treating stroke in humans.
    Type: Grant
    Filed: June 27, 2008
    Date of Patent: December 6, 2011
    Assignee: Paion Deutschland GmbH
    Inventors: Robert Medcalf, Mariola Söhngen, Wolfgang Söhngen, Wolf-Dieter Schleuning
  • NON-NEUROTOXIC PLASMINOGEN ACTIVATING FACTORS FOR TREATING OF STROKE
    Publication number: 20090263373
    Abstract: The invention concerns the use and the production of non-neurotoxic plasminogen activating factors, derived, for example, from the common vampire Desmodus rotundus (DSPA), for therapeutic treatment of stroke in humans. The invention provides a novel therapeutic base for treating stroke in humans.
    Type: Application
    Filed: August 22, 2008
    Publication date: October 22, 2009
    Inventors: Mariola SOHNGEN, Wolfgang Sohngen, Wolf-Dieter Schleuning, Robert Medcalf
  • NON-NEUROTOXIC PLASMINOGEN ACTIVATING FACTORS FOR TREATING OF STROKE
    Publication number: 20090004176
    Abstract: The invention pertains to the use and production of non-neurotoxic plasminogen activating factors e.g. of Desmodus rotundus (DSPA) for the therapeutic treatment of stroke in humans in order to provide a new therapeutic concept for treating stroke in humans.
    Type: Application
    Filed: June 27, 2008
    Publication date: January 1, 2009
    Inventors: Robert MEDCALF, Mariola Sohngen, Wolfgang Sohngen, Wolf-Dieter Schleuning
  • Glutamate Receptor Antagonists as Neuroprotectives
    Publication number: 20080213244
    Abstract: The invention relates to the use of inhibiting agents of t-PA-mediated activation of the glutamate receptor, for example of the NMDA type, as neuroprotectives.
    Type: Application
    Filed: May 5, 2004
    Publication date: September 4, 2008
    Inventor: Wolfgang Sohngen
  • Intravenous injection of plasminogen non-neurotoxic activators for treating cerebral stroke
    Publication number: 20080057050
    Abstract: The invention refers to the use of non-neurotoxic plasminogen activating factors, e.g., from Desmodus rotundus (DSPA) or genetically modified plasminogen activating factors, for example of human origin, for the therapeutic treatment of stroke in mammals.
    Type: Application
    Filed: July 26, 2007
    Publication date: March 6, 2008
    Inventors: Mariola Sohngen, Wolfgang Sohngen, Dirk Eyding, Yasir Alaa Al-Rawi
  • Intravenous injection of plasminogen non-neurotoxic activators for treating cerebral stroke
    Publication number: 20060135425
    Abstract: The invention refers to the use of non-neurotoxic plasminogen activating factors, e.g., from Desmodus rotundus (DSPA) or genetically modified plasminogen activating factors, for example of human origin, for the therapeutic treatment of stroke in mammals.
    Type: Application
    Filed: November 2, 2005
    Publication date: June 22, 2006
    Inventors: Mariola Sohngen, Wolfgang Sohngen, Dirk Eyding, Yasir Shafeek Al-Rawi
  • Non-neurotoxic plasminogen activating factors for treating stroke
    Publication number: 20050048027
    Abstract: The invention concerns the use and the production of non-neurotoxin plasminogen activating factors, derived for example from the common vampire Desmodus rotundus (DSPA), for therapeutic treatment of stroke in humans. The invention provides a novel therapeutic base for treating stroke in humans.
    Type: Application
    Filed: October 31, 2002
    Publication date: March 3, 2005
    Inventors: Mariola Sohngen, Wolfgang Sohngen, Wolf-Dieter Schleuning, Robert Medcalf